Etienne Dardenne

Etienne Dardenne serves as the Director and Head of Biology at Alphina Therapeutics since October 2024. Previously, Dardenne held various roles at Black Diamond Therapeutics from April 2020 to October 2024, culminating in the position of Associate Director. Dardenne's experience includes serving as a Senior Scientist at Pfizer from September 2018 to April 2020, leading pre-clinical projects focused on epigenetic and nuclear receptor signaling regulators. Prior to that, Dardenne worked as a Post Doctoral Associate at Weill Cornell Medical College, where research centered on neuroendocrine prostate cancer. Dardenne's academic background includes a PhD in Molecular Biology from Université Claude Bernard Lyon 1 and a Master's degree in Oncology and Cancer Biology, alongside extensive research credentials from positions in established institutions and companies.